Moleculin Biotech (MBRX) Short Interest Ratio & Short Volume $1.67 -0.14 (-7.73%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Moleculin Biotech Short Interest DataMoleculin Biotech (MBRX) has a short interest of 20,700 shares, representing 0.71% of the float (the number of shares available for trading by the public). This marks a -61.74% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 34,626 shares to cover all short positions.Current Short Interest20,700 sharesPrevious Short Interest54,100 sharesChange Vs. Previous Month-61.74%Dollar Volume Sold Short$57,339.00Short Interest Ratio0.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares3,191,000 sharesFloat Size2,900,000 sharesShort Percent of Float0.71%Today's Trading Volume59,276 sharesAverage Trading Volume34,626 sharesToday's Volume Vs. Average171% Short Selling Moleculin Biotech? Sign up to receive the latest short interest report for Moleculin Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMBRX Short Interest Over TimeMBRX Days to Cover Over TimeMBRX Percentage of Float Shorted Over Time Ad Porter & CompanyFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Moleculin Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202420,700 shares $57,339.00 -61.7%0.7%0.5 $2.77 11/15/202454,100 shares $146,611.00 -55.8%1.9%1.3 $2.71 10/31/2024122,400 shares $318,240.00 -28.6%4.5%3.8 $2.60 10/15/2024171,500 shares $399,595.00 +0.4%6.3%4.2 $2.33 9/30/2024170,900 shares $485,356.00 +36.5%6.2%4.3 $2.84 9/15/2024125,200 shares $304,236.00 +17.0%4.6%3.4 $2.43 Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024107,000 shares $272,850.00 +108.6%3.9%3.3 $2.55 8/15/202451,300 shares $114,399.00 +83.9%1.9%1.6 $2.23 7/31/202427,900 shares $87,885.00 +30.4%1.1%1 $3.15 7/15/202421,400 shares $90,308.00 -28.7%1.0%1 $4.22 6/30/202430,000 shares $105,600.00 +31.0%1.4%1.4 $3.52 6/15/202422,900 shares $94,806.00 +8.5%1.0%0.6 $4.14 5/31/202421,100 shares $100,647.00 -38.3%1.0%0.5 $4.77 5/15/202434,200 shares $168,264.00 +10.0%1.5%0.9 $4.92 4/30/202431,100 shares $156,122.00 +16.5%1.5%0.8 $5.02 4/15/202426,700 shares $119,082.00 -40.7%1.2%0.8 $4.46 3/31/202445,000 shares $265,950.00 +2,042.9%2.1%1.4 $5.91 3/15/20242,100 shares $15,576.75 -98.4%0.1%0.1 $7.42 2/29/2024134,400 shares $84,537.60 -2.4%N/A0.8 $0.63 2/15/2024137,700 shares $68,850.00 -37.4%N/A0.9 $0.50 1/31/2024220,000 shares $110,880.00 -8.5%N/A1.2 $0.50 1/15/2024240,300 shares $170,613.00 -23.8%N/A1.3 $0.71 12/31/2023315,300 shares $270,653.52 -7.5%N/A1.6 $0.86 12/15/2023340,800 shares $197,664.00 +35.3%N/A2.1 $0.58 11/30/2023251,900 shares $150,812.53 -15.2%N/A1.7 $0.60 11/15/2023296,900 shares $169,233.00 +59.7%N/A1.9 $0.57 10/31/2023185,900 shares $90,012.78 +131.8%N/A1.5 $0.48 10/15/202380,200 shares $36,090.00 -55.3%N/A0.7 $0.45 9/30/2023179,300 shares $76,650.75 +260.0%N/A1.2 $0.43 9/15/202349,800 shares $19,770.60 +30.7%N/A0.3 $0.40 8/31/202338,100 shares $21,336.00 -75.4%N/A0.2 $0.56 8/15/2023155,100 shares $94,455.90 +15.6%N/A1 $0.61 7/31/2023134,200 shares $84,975.44 +42.6%N/A0.7 $0.63 7/15/202394,100 shares $59,283.00 -20.8%N/A0.5 $0.63 6/30/2023118,800 shares $68,761.44 +611.4%N/A0.4 $0.58 6/15/202316,700 shares $9,853.00 +108.8%N/A0.1 $0.59 5/31/20238,000 shares $5,068.00 -59.4%N/A0 $0.63 5/15/202319,700 shares $12,139.14 +20.9%N/A0.1 $0.62 4/30/202316,300 shares $12,180.99 -30.3%0.1%0.1 $0.75 4/15/202323,400 shares $21,294.00 -14.6%0.1%0.1 $0.91Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 3/31/202327,400 shares $26,304.00 -26.3%0.1%0.4 $0.96 3/15/202337,200 shares $35,340.00 -13.9%0.1%0.5 $0.95 2/28/202343,200 shares $52,272.00 -30.1%0.2%0.5 $1.21 2/15/202361,800 shares $80,340.00 +56.9%0.2%0.7 $1.30 1/31/202339,400 shares $49,640.06 -49.0%0.1%0.4 $1.26 1/15/202377,200 shares $100,360.00 -34.9%0.3%0.8 $1.30 12/30/2022118,600 shares $125,716.00 +48.3%0.4%1.2 $1.06 12/15/202280,000 shares $110,400.00 -9.7%0.3%0.8 $1.38 11/30/202288,600 shares $127,584.00 +30.3%0.3%0.9 $1.44 11/15/202268,000 shares $64,593.20 +32.0%0.2%0.6 $0.95 10/31/202251,500 shares $51,500.00 -9.8%0.2%0.5 $1.00 10/15/202257,100 shares $57,100.00 -5.3%0.2%0.6 $1.00 9/30/202260,300 shares $63,918.00 -36.4%0.2%0.6 $1.06 9/15/202294,800 shares $134,616.00 -40.0%0.3%1 $1.42 8/31/2022158,100 shares $233,988.00 +59.2%0.6%2 $1.48 8/15/202299,300 shares $178,740.00 +85.6%0.4%2 $1.80 7/31/202253,500 shares $90,415.00 -54.7%0.2%1 $1.69 7/15/2022118,200 shares $195,467.34 +25.5%0.4%2 $1.65 6/30/202294,200 shares $136,590.00 -37.9%0.3%1.4 $1.45 6/15/2022151,600 shares $210,724.00 -39.0%0.5%1.9 $1.39 5/31/2022248,500 shares $372,750.00 +31.0%0.9%2.9 $1.50 5/15/2022189,700 shares $235,228.00 -37.0%0.7%1.9 $1.24 4/30/2022301,000 shares $478,590.00 -28.0%1.1%2.8 $1.59 4/15/2022418,300 shares $836,600.00 +0.6%1.5%3.5 $2.00 3/31/2022415,900 shares $740,302.00 -4.7%1.5%3.4 $1.78 3/15/2022436,400 shares $554,228.00 -9.6%1.6%2.4 $1.27 2/28/2022482,500 shares $670,675.00 +9.2%1.8%2.4 $1.39 2/15/2022441,900 shares $645,174.00 -9.9%1.7%1.8 $1.46 1/31/2022490,200 shares $740,202.00 -7.8%1.8%1.9 $1.51 1/15/2022531,600 shares $909,036.00 +2.0%2.0%1.9 $1.71 12/31/2021521,100 shares $969,246.00 -11.0%1.9%1.8 $1.86 12/15/2021585,400 shares $1.22 million +2.2%2.2%2.3 $2.08 11/30/2021572,600 shares $1.19 million -8.7%2.1%2.4 $2.07 11/15/2021626,800 shares $1.49 million -3.3%2.3%3.2 $2.38 10/29/2021648,000 shares $1.71 million -6.1%2.4%3.5 $2.64 10/15/2021690,400 shares $1.87 million +3.6%2.6%4 $2.71 9/30/2021666,700 shares $2.00 million -6.3%2.5%3.8 $3.00 9/15/2021711,400 shares $2.07 million -5.6%2.7%3.7 $2.91 8/31/2021753,900 shares $2.32 million +5.4%2.8%3.5 $3.08 8/13/2021715,200 shares $2.12 million -7.3%2.7%2.9 $2.97 7/30/2021771,800 shares $2.41 million -18.8%2.9%2.9 $3.12 7/15/2021949,900 shares $3.25 million -1.0%3.6%3.3 $3.42 6/30/2021959,300 shares $3.52 million +17.8%3.6%1.7 $3.67 6/15/2021814,600 shares $3.08 million -13.8%3.1%0.7 $3.78 5/28/2021944,700 shares $3.50 million -14.9%3.5%0.8 $3.70 5/14/20211,110,000 shares $3.63 million -4.3%4.2%0.9 $3.27 4/30/20211,160,000 shares $4.21 million +26.7%4.4%0.7 $3.63 4/15/2021915,500 shares $3.38 million +78.0%3.4%0.3 $3.69 3/31/2021514,200 shares $2.19 million +70.9%1.9%0.2 $4.25 3/15/2021300,800 shares $1.34 million -50.1%1.1%0.1 $4.44Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 2/26/2021602,500 shares $2.62 million +44.7%2.6%0.3 $4.35 2/12/2021416,500 shares $2.23 million -84.9%1.8%0.2 $5.36 1/29/20212,760,000 shares $16.06 million +8.2%12.6%1.4 $5.82 1/15/20212,550,000 shares $15.45 million +4.9%N/A1 $6.06 12/31/20202,430,000 shares $12.17 million +4.7%N/A1.2 $5.01 12/15/20202,320,000 shares $10.75 million -0.4%N/A1.6 $4.63 11/30/20202,330,000 shares $10.82 million -7.2%N/A1.7 $4.64 11/15/20202,510,000 shares $11.58 million -3.5%N/A5 $4.61 10/30/20202,600,000 shares $11.23 million -11.3%N/A4.9 $4.32 10/15/20202,930,000 shares $14.29 million -5.5%N/A4.1 $4.88 9/30/20203,100,000 shares $15.12 million +2.0%N/A1 $4.88 9/15/20203,040,000 shares $14.85 million -10.3%N/A1 $4.88 8/31/20203,390,000 shares $17.83 million -7.6%N/A1.1 $5.26 8/14/20203,670,000 shares $21.58 million -5.4%N/A1.1 $5.88 7/31/20203,880,000 shares $26.77 million +19.0%N/A1.2 $6.90 7/15/20203,260,000 shares $20.93 million -11.7%N/A1 $6.42 6/30/20203,690,000 shares $21.43 million -13.2%N/A0.7 $5.81 6/15/20204,250,000 shares $28.56 million -3.2%N/A0.8 $6.72 5/29/20204,390,000 shares $28.71 million +8.7%N/A0.7 $6.54 5/15/20204,040,000 shares $25.94 million -28.2%N/A0.7 $6.42 4/30/20205,630,000 shares $36.82 million +10.8%N/A1 $6.54 4/15/20205,080,000 shares $38.40 million +213.6%N/A0.9 $7.56 3/31/20201,620,000 shares $1.85 million +202.9%N/A0.4 $1.14 3/13/2020534,900 shares $604,437.00 -27.4%1.4%1.5 $1.13 2/28/2020736,300 shares $404,965.00 -35.4%1.9%1.1 $0.55 2/14/20201,140,000 shares $649,800.00 -16.8%2.9%1.8 $0.57 1/31/20201,370,000 shares $945,300.00 -4.2%3.5%2.5 $0.69 1/15/20201,430,000 shares $1.07 million -20.1%3.7%6.1 $0.75 12/31/20191,790,000 shares $1.68 million -6.3%4.6%7.8 $0.94 MBRX Short Interest - Frequently Asked Questions What is Moleculin Biotech's current short interest? Short interest is the volume of Moleculin Biotech shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 20,700 shares of MBRX short. 0.71% of Moleculin Biotech's shares are currently sold short. Learn More on Moleculin Biotech's current short interest. What is a good short interest percentage for Moleculin Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.71% of Moleculin Biotech's floating shares are currently sold short. Is Moleculin Biotech's short interest increasing or decreasing? Moleculin Biotech saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 20,700 shares, a decrease of 61.7% from the previous total of 54,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Moleculin Biotech's float size? Moleculin Biotech currently has issued a total of 3,191,000 shares. Some of Moleculin Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moleculin Biotech currently has a public float of 2,900,000 shares. How does Moleculin Biotech's short interest compare to its competitors? 0.71% of Moleculin Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Moleculin Biotech: LAVA Therapeutics (0.15%), Enlivex Therapeutics Ltd. (1.00%), Lakeshore Biopharma Co., Ltd. (0.91%), Akari Therapeutics, Plc (0.47%), Senti Biosciences, Inc. (2.05%), MiNK Therapeutics, Inc. (0.43%), Chemomab Therapeutics Ltd. (0.62%), Equillium, Inc. (0.76%), Mannatech, Incorporated (0.41%), Athira Pharma, Inc. (5.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Moleculin Biotech stock? Short selling MBRX is an investing strategy that aims to generate trading profit from Moleculin Biotech as its price is falling. MBRX shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Moleculin Biotech? A short squeeze for Moleculin Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBRX, which in turn drives the price of the stock up even further. How often is Moleculin Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBRX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies LAVA Therapeutics Short Squeeze Enlivex Therapeutics Short Squeeze Lakeshore Biopharma Short Squeeze Akari Therapeutics Short Squeeze Senti Biosciences Short Squeeze MiNK Therapeutics Short Squeeze Chemomab Therapeutics Short Squeeze Equillium Short Squeeze Mannatech Short Squeeze Athira Pharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MBRX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBRX Stock Alerts